Cenntro (CENN) stock was 45% lower pre-bell Wednesday, extending the 85% loss in the prior session.
Amdocs (DOX) stock was down 41% following the company's fiscal Q4 results.
Nurix Therapeutics (NRIX) shares were 31% lower after the company said that Sanofi (SNY) had decided to discontinue the phase 1 clinical trial and terminate development of SAR448272, an oral STAT6 degrader co-developed under the companies' 2019 partnership.
Taboola (TBLA) stock was down 19% after the company posted Q3 financial results.
Skyworks Solutions (SWKS) shares were down 14% after the company reported lower fiscal Q4 adjusted earnings and revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments